The global radiotherapy market exhibited moderate growth during 2015-2020.
Looking forward, the analyst expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Radiotherapy, also known as radiation therapy, is used to slow down the growth of cancer cells and shrink tumors. It destroys the genetic material of cancer cells using high-energy particles or waves, such as x-rays, gamma rays, electron beams, or protons. It can be combined with other cancer treatments, such as surgery, chemotherapy, and immunotherapy, to improve their effectiveness. At present, it is offered to patients depending on their cancer type, size and location of the tumor, medical history, and age and medical conditions. Radiotherapy Market Trends: The rising prevalence of cancer on account of unhealthy dietary patterns, lack of physical activities, growing air pollution, and the increasing number of alcohol and tobacco consumption represents one of the key factors strengthening the growth of the market. Moreover, the risk of developing cancer rises dramatically with age as the tendency for cellular repair is less effective in older individuals. As a result, the rising geriatric population across the globe is acting as another significant growth-inducing factor. Apart from this, the development of effective, low-cost, and easy-to-use radiotherapy products is bolstering the growth of the market growth. In addition, modern radiotherapy techniques, such as three-dimensional (3D) conformal, intensity-modulated, and image-guided, deliver a lower dose of radiation to healthy tissues while a higher dose to the tumor. They also improve organ-at-risk (OAR) sparing and provide no physical sensation to patients. This is increasing their adoption in multiple applications and settings in chronic disease treatment, which, in turn, is catalyzing the demand for radiotherapy around the world. Furthermore, the market is projected to experience growth on account of the rising healthcare expenditure in both emerging and developed economies.
Key Market Segmentation: the analyst provides an analysis of the key trends in each sub-segment of the global radiotherapy market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, application and end user.
Breakup by Application: Skin and Lip Cancer Head and Neck Cancer Breast Cancer Prostate Cancer Cervical Cancer Lung Cancer Others
Breakup by End User: Hospitals Cancer Research Institutes Ambulatory and Radiotherapy Centers
Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB (publ), General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health) and Siemens Healthineers AG (Siemens AG). Key Questions Answered in This Report: How has the global radiotherapy market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global radiotherapy market? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the application? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global radiotherapy market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
The global surrogacy market reached a value of US$ 161.83 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 240.56 Million by 2027, exhibiting a CAGR of 6.62% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
The global alopecia treatment market reached a value of US$ 3 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 3.9 Billion by 2027, exhibiting a CAGR of 4.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as...
The global intravenous solutions market reached a value of US$ 13.2 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 18.6 Billion by 2027, exhibiting a CAGR of 5.96% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
461 pages •
By Global Industry Analysts
• Feb 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass Research Platform - Complimentary...
200 pages •
By The Business Research Company
• May 2022
Major players in the oncology devices market are Eckert & Ziegler BEBIG, Oncura Inc, GE Healthcare, Medtronic plc, Varian Medical Systems Inc, Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, and IBA Group. The global oncology devices market is expected to grow from $91.47 billion in 2021 to $107.81 billion...
Executive Summary According to the report, the Global Bracing and Support (B&S) Market is projected to display impressive growth during 2022–2027. The Global Bracing and Support (B&S) Market was valued at USD 4433.83 Million in the year 2021 with the North American region leading the regional market share. The key factors...
The autotransfusion devices market is expected to grow from US$ 1,000.26 million in 2021 to US$ 1,331.99 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028. Rapid increase in chronic diseases, rise in transplants, and difficulty in obtaining blood groups across the globe are driving the growth of the market....
The Live Cell Imaging market is projected to register a CAGR of 7.29% during the forecast period with a market size of USD 1,801.89 million in 2021 and expected to reach USD 2,766.27 million by 2027. The COVID-19 pandemic had a severe impact on the market as there were supply chain disruptions due to lockdown. However, the increasing...
The global aloe vera gel market reached a value of US$ 243.6 Million in 2021. Looking forward, the analyst expects the market to reach US$ 381.1 Million by 2027, exhibiting a CAGR of 7.56% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
120 pages •
By Infiniti Research Limited
• May 2022
Global Radiation Detection Monitoring And Safety Market 2022-2026 The analyst has been monitoring the radiation detection monitoring and safety market and it is poised to grow by $ 1.48 bn during 2022-2026, accelerating at a CAGR of 7.21% during the forecast period. Our report on the radiation detection monitoring and safety...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.